AC T16699
XX
ID T16699
XX
DT 10.03.2005 (created); nvo.
DT 30.04.2012 (updated); uat.
CO Copyright (C), QIAGEN.
XX
FA B-Myb
XX
SY BMYB.
XX
OS Mammalia
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia
XX
IN T15118 CBP; Mammalia.
IN T08641 NCOR1-isoform1; mouse, Mus musculus.
IN T15350 PARP; Mammalia.
IN T08326 Sp1; Mammalia.
XX
MX M00913 V$MYB_Q5_01.
MX M08890 V$MYB_Q5_02.
XX
BS R38634.
XX
DR TRANSPATH: MO000046307.
XX
RN [1]; RE0027825.
RX PUBMED: 11264176.
RA Muller-Tidow C., Wang W., Idos G. E., Diederichs S., Yang R., Readhead C., Berdel W. E., Serve H., Saville M., Watson R., Koeffler H. P.
RT Cyclin A1 directly interacts with B-myb and cyclin A1/cdk2 phosphorylate B-myb at functionally important serine and threonine residues: tissue-specific regulation of B-myb function.
RL Blood 97:2091-7 (2001).
RN [2]; RE0029516.
RX PUBMED: 11973331.
RA Tanno B., Negroni A., Vitali R., Pirozzoli M. C., Cesi V., Mancini C., Calabretta B., Raschella G.
RT Expression of insulin-like growth factor-binding protein 5 in neuroblastoma cells is regulated at the transcriptional level by c-Myb and B-Myb via direct and indirect mechanisms.
RL J. Biol. Chem. 277:23172-80 (2002).
RN [3]; RE0033215.
RX PUBMED: 11733503.
RA Johnson L. R., Johnson T. K., Desler M., Luster T. A., Nowling T., Lewis R. E., Rizzino A.
RT Effects of B-Myb on gene transcription: phosphorylation-dependent activity ans acetylation by p300.
RL J. Biol. Chem. 277:4088-97 (2002).
RN [4]; RE0039529.
RX PUBMED: 10871850.
RA Charrasse S., Carena I., Brondani V., Klempnauer K. H., Ferrari S.
RT Degradation of B-Myb by ubiquitin-mediated proteolysis: involvement of the Cdc34-SCF(p45Skp2) pathway
RL Oncogene 19:2986-95 (2000).
RN [5]; RE0039822.
RX PUBMED: 10656684.
RA De Falco G., Bagella L., Claudio P. P., de Luca A., Fu Y., Calabretta B., Sala A., Giordano A.
RT Physical interaction between CDK9 and B-Myb results in suppression of B-Myb gene autoregulation
RL Oncogene 19:373-9 (2000).
RN [6]; RE0046317.
RX PUBMED: 10645009.
RA Horstmann S., Ferrari S., Klempnauer K. H.
RT Regulation of B-Myb activity by cyclin D1
RL Oncogene 19:298-306 (2000).
RN [7]; RE0046320.
RX PUBMED: 10744766.
RA Cervellera M. N., Sala A.
RT Poly(ADP-ribose) polymerase is a B-MYB coactivator
RL J. Biol. Chem. 275:10692-6 (2000).
RN [8]; RE0046322.
RX PUBMED: 11997503.
RA Li X., McDonnell D. P.
RT The transcription factor B-Myb is maintained in an inhibited state in target cells through its interaction with the nuclear corepressors N-CoR and SMRT
RL Mol. Cell. Biol. 22:3663-73 (2002).
RN [9]; RE0046323.
RX PUBMED: 12645566.
RA Seong H. A., Kim K. T., Ha H.
RT Enhancement of B-MYB transcriptional activity by ZPR9, a novel zinc finger protein
RL J. Biol. Chem. 278:9655-62 (2003).
RN [10]; RE0046326.
RX PUBMED: 15606792.
RA Lang G., Gombert W. M., Gould H. J.
RT A transcriptional regulatory element in the coding sequence of the human Bcl-2 gene
RL Immunology 114:25-36 (2005).
RN [11]; RE0049619.
RX PUBMED: 16055500.
RA Kurahashi T., Nomura T., Kanei-Ishii C., Shinkai Y., Ishii S.
RT The Wnt-NLK signaling pathway inhibits A-Myb activity by inhibiting the association with coactivator CBP and methylating histone H3.
RL Mol. Biol. Cell 16:4705-4713 (2005).
XX
//